Genentech to report progress at the American Society of Clinical Oncology
Genentech will present important new data from studies of several cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) from June 1-5, 2012, in Chicago.
This page is intended to be a media resource for Genentech developments at ASCO. It will be updated frequently throughout the meeting.
Related news releases
New Data on Important Progress for People with Advanced Cancers (5/15/2012)
Medicine Reduced Risk of a Difficult-to-Treat Ovarian Cancer From Getting Worse (6/1/2012)
Pivotal Trial of Investigational Breast Cancer Medicine Showed Reduced Risk of Cancer Worsening (6/2/2012)
Metastatic Colorectal Cancer Medicine Helped People Live Longer (6/2/2012)
Watch interviews with Genentech scientists to better understand our innovative approach to research.
Jeff Settleman explains how biomarkers identify which patients may benefit from certain treatments.
Frederic de Sauvage explains the relationship between the Hedgehog signaling pathway and cancer